Page last updated: 2024-11-09

meranzin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

meranzin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1803558
SCHEMBL ID14315527
MeSH IDM0495648

Synonyms (16)

Synonym
meranzin
8-[[(2s)-3,3-dimethyloxiran-2-yl]methyl]-7-methoxychromen-2-one
SCHEMBL14315527
2h-1-benzopyran-2-one, 8-[[(2s)-3,3-dimethyloxiranyl]methyl]-7-methoxy-
2h-1-benzopyran-2-one, 8-[[(2s)-3,3-dimethyl-2-oxiranyl]methyl]-7-methoxy-
2h-1-benzopyran-2-one, 8-[(3,3-dimethyloxiranyl)methyl]-7-methoxy-, (s)-
LSZONYLDFHGRDP-LBPRGKRZSA-N
coumarin, 8-(2,3-epoxy-3-methylbutyl)-7-methoxy-, (-)-
(-)-meranzin
merancin
AC-34114
HY-N3298
CS-0023841
MS-23666
mfcd02683834
AKOS040760112

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The present study aimed to develop a strategy involving quantitative analysis of multicomponents by single marker in combination with high-performance liquid chromatography fingerprint qualitative analysis for performing the quality control of Aurantii Fructus."( Quantitative analysis of multicomponents by single marker combined with HPLC fingerprint qualitative analyses for comprehensive evaluation of Aurantii Fructus.
Cai, X; Huang, D; Lei, Y; Lin, M; Luo, K; Sun, Z; Tan, S; Wang, Y; Xia, X; Yan, J; Zhang, Y, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]